541 related articles for article (PubMed ID: 26657484)
1. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
2. Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies.
Yu X; Baruah K; Harvey DJ; Vasiljevic S; Alonzi DS; Song BD; Higgins MK; Bowden TA; Scanlan CN; Crispin M
J Am Chem Soc; 2013 Jul; 135(26):9723-32. PubMed ID: 23745692
[TBL] [Abstract][Full Text] [Related]
3. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
[TBL] [Abstract][Full Text] [Related]
4. Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity.
Derer S; Glorius P; Schlaeth M; Lohse S; Klausz K; Muchhal U; Desjarlais JR; Humpe A; Valerius T; Peipp M
MAbs; 2014; 6(2):409-21. PubMed ID: 24492248
[TBL] [Abstract][Full Text] [Related]
5. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
6. rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
Spirig R; Campbell IK; Koernig S; Chen CG; Lewis BJB; Butcher R; Muir I; Taylor S; Chia J; Leong D; Simmonds J; Scotney P; Schmidt P; Fabri L; Hofmann A; Jordi M; Spycher MO; Cattepoel S; Brasseit J; Panousis C; Rowe T; Branch DR; Baz Morelli A; Käsermann F; Zuercher AW
J Immunol; 2018 Apr; 200(8):2542-2553. PubMed ID: 29531170
[TBL] [Abstract][Full Text] [Related]
7. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
8. Engineering the interactions between a plant-produced HIV antibody and human Fc receptors.
Stelter S; Paul MJ; Teh AY; Grandits M; Altmann F; Vanier J; Bardor M; Castilho A; Allen RL; Ma JK
Plant Biotechnol J; 2020 Feb; 18(2):402-414. PubMed ID: 31301102
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Voice JK; Lachmann PJ
Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of a human Fc fragment engineered for lack of effector functions.
Oganesyan V; Gao C; Shirinian L; Wu H; Dall'Acqua WF
Acta Crystallogr D Biol Crystallogr; 2008 Jun; 64(Pt 6):700-4. PubMed ID: 18560159
[TBL] [Abstract][Full Text] [Related]
11. Engineered humanized dimeric forms of IgG are more effective antibodies.
Caron PC; Laird W; Co MS; Avdalovic NM; Queen C; Scheinberg DA
J Exp Med; 1992 Oct; 176(4):1191-5. PubMed ID: 1402660
[TBL] [Abstract][Full Text] [Related]
12. Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131).
Mimoto F; Katada H; Kadono S; Igawa T; Kuramochi T; Muraoka M; Wada Y; Haraya K; Miyazaki T; Hattori K
Protein Eng Des Sel; 2013 Oct; 26(10):589-98. PubMed ID: 23744091
[TBL] [Abstract][Full Text] [Related]
13. IgG-Fc glycoengineering in non-mammalian expression hosts.
Loos A; Steinkellner H
Arch Biochem Biophys; 2012 Oct; 526(2):167-73. PubMed ID: 22634260
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.
Mizushima T; Yagi H; Takemoto E; Shibata-Koyama M; Isoda Y; Iida S; Masuda K; Satoh M; Kato K
Genes Cells; 2011 Nov; 16(11):1071-80. PubMed ID: 22023369
[TBL] [Abstract][Full Text] [Related]
15. Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII.
Ghirlando R; Keown MB; Mackay GA; Lewis MS; Unkeless JC; Gould HJ
Biochemistry; 1995 Oct; 34(41):13320-7. PubMed ID: 7577916
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.
Bauer-Smith H; Sudol ASL; Beers SA; Crispin M
Biochim Biophys Acta Gen Subj; 2023 Nov; 1867(11):130448. PubMed ID: 37652365
[TBL] [Abstract][Full Text] [Related]
17. Distinct effector functions mediated by Fc regions of bovine IgG subclasses and their interaction with Fc gamma receptors.
Noble A; Paudyal B; Schwartz JC; Mwangi W; Munir D; Tchilian E; Hammond JA; Graham SP
Front Immunol; 2023; 14():1286903. PubMed ID: 38077405
[TBL] [Abstract][Full Text] [Related]
18. Impairment by glycation of immunoglobulin G Fc fragment function.
Dolhofer-Bliesener R; Gerbitz KD
Scand J Clin Lab Invest; 1990 Nov; 50(7):739-46. PubMed ID: 2149885
[TBL] [Abstract][Full Text] [Related]
19. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.
Lund J; Takahashi N; Nakagawa H; Goodall M; Bentley T; Hindley SA; Tyler R; Jefferis R
Mol Immunol; 1993 Jun; 30(8):741-8. PubMed ID: 8502242
[TBL] [Abstract][Full Text] [Related]
20. Recognition sites on human IgG for Fc gamma receptors: the role of glycosylation.
Jefferis R; Lund J; Goodall M
Immunol Lett; 1995 Jan; 44(2-3):111-7. PubMed ID: 7797239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]